相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabinoid receptor CB2 protects against balloon-induced neointima formation
Filippo Molica et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bela Horvath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques
Fabrizio Montecucco et al.
EUROPEAN HEART JOURNAL (2012)
Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
Servio H. Ramirez et al.
JOURNAL OF NEUROSCIENCE (2012)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
Juan G. Zarruk et al.
STROKE (2012)
Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands
Brady K. Atwood et al.
MOLECULAR PHARMACOLOGY (2012)
Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway
Natasha L. Grimsey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Mechanisms of Osteoclastogenesis Inhibition by a Novel Class of Biphenyl-Type Cannabinoid CB2 Receptor Inverse Agonists
Wolfgang Schuehly et al.
CHEMISTRY & BIOLOGY (2011)
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
Federica Barutta et al.
DIABETES (2011)
N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis
Ayelet Cohen-Yeshurun et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Endocannabinoid content in fetal bovine sera - Unexpected effects on mononuclear cells and osteoclastogenesis
Janine Marazzi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo
Friedrich Felix Hoyer et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice
Florian Willecke et al.
PLOS ONE (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice
Dianne J. M. Delsing et al.
OPEN CARDIOVASCULAR MEDICINE JOURNAL (2011)
Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice
Courtney D. Netherland et al.
ATHEROSCLEROSIS (2010)
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
Barbara Bosier et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
Tricia H. Smith et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
Partha Mukhopadhyay et al.
CARDIOVASCULAR RESEARCH (2010)
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice
Yan Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
Sasidhar Murikinati et al.
FASEB JOURNAL (2010)
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules
Yan Zhao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure
Florian Weis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Cannabinoid CB1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders New Hopes, Old Concerns?
Pal Pacher
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Myocardial repair/remodelling following infarction: roles of local factors
Yao Sun
CARDIOVASCULAR RESEARCH (2009)
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages
Li-sheng Jiang et al.
CARDIOVASCULAR RESEARCH (2009)
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy
Nicole Defer et al.
FASEB JOURNAL (2009)
CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
Fabrizio Montecucco et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Fine-tuning of GPCR activity by receptor-interacting proteins
Stefanie L. Ritter et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
Fabrizio Montecucco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Role of smooth muscle cells in the initiation and early progression of atherosclerosis
Amanda C. Doran et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration
M. Rajesh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning
P. Pacher et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
CB2 receptor-mediated migration of immune cells: it can go either way
A. M. Miller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart
Amir Reza Hajrasouliha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis
Natalie E. Freeman-Anderson et al.
JOURNAL OF LIPID RESEARCH (2008)
Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury
M. Zhang et al.
NEUROSCIENCE (2008)
Pivotal Advance:: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Mohanraj Rajesh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts
Philippe Lepicier et al.
LIFE SCIENCES (2007)
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Pharmacologic approaches to restenosis prevention
John S. Douglas
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
Ming Zhang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Vascular responses to drug eluting stents - Importance of delayed healing
Aloke V. Finn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
Mechanisms of vascular smooth muscle cell migration
William T. Gerthoffer
CIRCULATION RESEARCH (2007)
Drug-eluting stent and coronary thrombosis -: Biological mechanisms and clinical implications
Thomas F. Luescher et al.
CIRCULATION (2007)
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain
John C. Ashton et al.
NEUROSCIENCE LETTERS (2007)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
Sharmistha Ghosh et al.
MOLECULAR IMMUNOLOGY (2006)
2-arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts
Jens A. Wagner et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties
G Milman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production
YA Shmist et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism
NJ Underdown et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors
JL Shoemaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
EJ Carrier et al.
MOLECULAR PHARMACOLOGY (2004)
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN
C Di Filippo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
GPCR-interacting proteins (GIPs):: nature and functions
J Bockaert et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Chemokines - Key regulators of mononuclear cell recruitment in atherosclerotic vascular disease
C Weber et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Cannabinoid receptor-mediated regulation of intracellular calcium by Δ9-tetrahydrocannabinol in resting T cells
GK Rao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model
X Ni et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
The cannabinoid system and immune modulation
TW Klein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism
S Kishimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Endocannabinoids protect the rat isolated heart against ischaemia
P Lépicier et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Medical progress: Heart failure
M Jessup et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart
JF Bouchard et al.
LIFE SCIENCES (2003)
Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells
C Zoratti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma
M Aikawa et al.
CIRCULATION (2002)
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts
M Joyeux et al.
CARDIOVASCULAR RESEARCH (2002)
Resorcinol derivatives:: A novel template for the development of cannabinoid CB1/CB2 and CB2-selective agonists
JL Wiley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion
AV Krylatov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2001)
Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells
Y Kobayashi et al.
JOURNAL OF BIOCHEMISTRY (2001)
Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide
C Lagneux et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60 -: Possible involvement of the CB2 receptor in cell differentiation
JM Derocq et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
NE Buckley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
The mechanisms of coronary restenosis: insights from experimental models
GAA Ferns et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2000)
分享论文
